Our global life sciences practice comprises a multi-disciplinary team of over 90 highly experienced lawyers.
We act for companies and their investors across the industry, including in the pharmaceuticals, biotech, medtech, diagnostics and healthcare sectors.
The practice operates on a cross-border basis and covers the full spectrum of legal support. We advise on mergers and acquisitions, commercial transactions (including licensing and collaborations), IP (both contentious and non-contentious), capital markets and finance, regulatory and dispute resolution. Our international network ensures that we have a ready resource of expertise in a number of jurisdictions, including those in emerging markets, and that we are well positioned to advise on cross-border work.
Recognition for our work
Allen & Overy is known for its work on high-value life sciences transactions and it counts a number of significant market leaders amongst its clients.
Chambers & Partners UK 2012 (Life Sciences)
“This team has impressive transactional capabilities. These lawyers are completely committed to their clients and have an outstanding work ethic,” say sources.
Chambers & Partners UK 2011 (Life Sciences)
Competition and IP – particularly patent litigation – are the outstanding strengths of this magic circle practice. It is also able to advise on a wide range of other matters in the pharma and life sciences field, including M&A, regulatory, public law and employment, drawing upon the firm’s multidisciplinary capacity.
Chambers & Partners Europe 2011 (France: Life Sciences)